Merck sets up $240M Alydia Health buyout to beef up its future Organon women's health spinout

Shortly after unveiling plans to spin its multibillion-dollar women’s health portfolio into the new company Organon, Merck & Co. has already lined up what will be its first acquisition: Alydia Health, which makes a device designed to prevent a mother's death during childbirth.